questionsmedicales.fr
Eucaryotes
Champignons
Deuteromycota
Chrysosporium
Chrysosporium : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Infections fongiques
Mycologie
Culture des champignons
PCR
Biopsie
Infections fongiques
Symptômes
Infections fongiques
Tests sérologiques
Infections fongiques
Symptômes
5
Symptômes
Infections fongiques
Infections cutanées
Chrysosporium
Infections pulmonaires
Symptômes
Infections systémiques
Chrysosporium
Prévention
5
Prévention
Infections fongiques
Immunodépression
Prévention
Prévention
Infections fongiques
Traitements
5
Antifongiques
Chrysosporium
Traitement
Infections fongiques
Durée du traitement
Antifongiques
Effets secondaires
Antifongiques
Hospitalisation
Infections fongiques
Complications
5
Complications
Infections fongiques
Mortalité
Infections fongiques
Gestion des complications
Antifongiques
Infections récurrentes
Immunodépression
Facteurs de risque
5
Facteurs de risque
Immunodépression
Personnes âgées
Facteurs de risque
Diabète
Infections fongiques
Immunosuppresseurs
Facteurs de risque
Voyages
Infections fongiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Chrysosporium : Questions médicales les plus fréquentes",
"headline": "Chrysosporium : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Chrysosporium : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-07",
"dateModified": "2025-05-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Chrysosporium"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Deuteromycota",
"url": "https://questionsmedicales.fr/mesh/D003904",
"about": {
"@type": "MedicalCondition",
"name": "Deuteromycota",
"code": {
"@type": "MedicalCode",
"code": "D003904",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.300.381"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Chrysosporium",
"alternateName": "Chrysosporium",
"code": {
"@type": "MedicalCode",
"code": "D002912",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Anwei Chen",
"url": "https://questionsmedicales.fr/author/Anwei%20Chen",
"affiliation": {
"@type": "Organization",
"name": "College of Resources and Environment, Hunan Agricultural University, Changsha 410128, PR China. Electronic address: A.Chen@hunau.edu.cn."
}
},
{
"@type": "Person",
"name": "Liang Hu",
"url": "https://questionsmedicales.fr/author/Liang%20Hu",
"affiliation": {
"@type": "Organization",
"name": "School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China. Electronic address: huliang2018@csu.edu.cn."
}
},
{
"@type": "Person",
"name": "Sheng-Tao Yang",
"url": "https://questionsmedicales.fr/author/Sheng-Tao%20Yang",
"affiliation": {
"@type": "Organization",
"name": "College of Chemistry and Environment Protection Engineering, Southwest Minzu University, Chengdu, 610041, PR China. Electronic address: yangst@pku.edu.cn."
}
},
{
"@type": "Person",
"name": "Ni He",
"url": "https://questionsmedicales.fr/author/Ni%20He",
"affiliation": {
"@type": "Organization",
"name": "School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China."
}
},
{
"@type": "Person",
"name": "Motoyuki Shimizu",
"url": "https://questionsmedicales.fr/author/Motoyuki%20Shimizu",
"affiliation": {
"@type": "Organization",
"name": "Department of Applied Biological Chemistry, Faculty of Agriculture, Meijo University, Nagoya, Aichi 468-8502, Japan. Electronic address: moshimi@meijo-u.ac.jp."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment.",
"datePublished": "2022-09-06",
"url": "https://questionsmedicales.fr/article/36068430",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40264-022-01216-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ferric Carboxymaltose in Heart Failure with Iron Deficiency.",
"datePublished": "2023-08-26",
"url": "https://questionsmedicales.fr/article/37632463",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1056/NEJMoa2304968"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ferric Pyrophosphate Forms Soluble Iron Coordination Complexes with Zinc Compounds and Solubilizing Agents in Extruded Rice and Predicts Increased Iron Solubility and Bioavailability in Young Women.",
"datePublished": "2022-12-24",
"url": "https://questionsmedicales.fr/article/36931746",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.tjnut.2022.12.003"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Systematic Review, Meta-Analysis, and Indirect Comparison of Blindly Adjudicated Cardiovascular Event Incidence with Ferric Derisomaltose, Ferric Carboxymaltose, and Iron Sucrose.",
"datePublished": "2022-08-10",
"url": "https://questionsmedicales.fr/article/35947351",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12325-022-02242-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study.",
"datePublished": "2022-07-06",
"url": "https://questionsmedicales.fr/article/35790696",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12185-022-03401-0"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Eucaryotes",
"item": "https://questionsmedicales.fr/mesh/D056890"
},
{
"@type": "ListItem",
"position": 3,
"name": "Champignons",
"item": "https://questionsmedicales.fr/mesh/D005658"
},
{
"@type": "ListItem",
"position": 4,
"name": "Deuteromycota",
"item": "https://questionsmedicales.fr/mesh/D003904"
},
{
"@type": "ListItem",
"position": 5,
"name": "Chrysosporium",
"item": "https://questionsmedicales.fr/mesh/D002912"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Chrysosporium - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Chrysosporium",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Chrysosporium",
"description": "Comment diagnostiquer une infection par Chrysosporium ?\nQuels tests sont utilisés pour identifier Chrysosporium ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes indiquent une infection par Chrysosporium ?\nPeut-on utiliser des tests sérologiques pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Ferric+Compounds#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Chrysosporium",
"description": "Quels sont les symptômes courants d'une infection fongique ?\nLes infections cutanées par Chrysosporium sont-elles fréquentes ?\nComment se manifestent les infections pulmonaires ?\nLes infections systémiques sont-elles graves ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Ferric+Compounds#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Chrysosporium",
"description": "Comment prévenir les infections par Chrysosporium ?\nLes personnes immunodéprimées doivent-elles prendre des précautions ?\nLe port de gants est-il recommandé lors de manipulations ?\nLes vaccinations aident-elles à prévenir ces infections ?\nL'hygiène personnelle joue-t-elle un rôle dans la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Ferric+Compounds#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Chrysosporium",
"description": "Quels traitements sont efficaces contre Chrysosporium ?\nLes traitements varient-ils selon la gravité de l'infection ?\nCombien de temps dure le traitement antifongique ?\nDes effets secondaires sont-ils associés aux antifongiques ?\nLes infections par Chrysosporium nécessitent-elles une hospitalisation ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Ferric+Compounds#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Chrysosporium",
"description": "Quelles complications peuvent survenir avec Chrysosporium ?\nLes infections par Chrysosporium peuvent-elles être mortelles ?\nComment les complications sont-elles gérées ?\nLes complications affectent-elles le pronostic ?\nLes infections récurrentes sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Ferric+Compounds#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Chrysosporium",
"description": "Quels sont les principaux facteurs de risque d'infection ?\nLes personnes âgées sont-elles plus à risque ?\nLe diabète augmente-t-il le risque d'infection fongique ?\nLes traitements immunosuppresseurs sont-ils un facteur de risque ?\nLes voyages dans des zones tropicales augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Ferric+Compounds#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par Chrysosporium ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen microscopique et la culture du champignon."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier Chrysosporium ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de culture et des techniques moléculaires comme la PCR peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles nécessaires pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des biopsies peuvent être nécessaires pour confirmer l'infection fongique."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection par Chrysosporium ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des lésions cutanées, des infections pulmonaires ou systémiques."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des tests sérologiques pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques ne sont généralement pas fiables pour Chrysosporium."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une infection fongique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, toux, éruptions cutanées et fatigue."
}
},
{
"@type": "Question",
"name": "Les infections cutanées par Chrysosporium sont-elles fréquentes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent provoquer des lésions cutanées et des démangeaisons."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les infections pulmonaires ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles se manifestent par une toux persistante, des douleurs thoraciques et des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Les infections systémiques sont-elles graves ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être graves et nécessitent une attention médicale immédiate."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et de l'état immunitaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par Chrysosporium ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition à des environnements humides et à des matériaux contaminés aide à prévenir."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées doivent-elles prendre des précautions ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles doivent éviter les environnements à risque et consulter un médecin régulièrement."
}
},
{
"@type": "Question",
"name": "Le port de gants est-il recommandé lors de manipulations ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le port de gants lors de la manipulation de terre ou de matériaux potentiellement contaminés est conseillé."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles à prévenir ces infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il n'existe pas de vaccin spécifique contre les infections par Chrysosporium."
}
},
{
"@type": "Question",
"name": "L'hygiène personnelle joue-t-elle un rôle dans la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hygiène personnelle peut réduire le risque d'infections fongiques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces contre Chrysosporium ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antifongiques comme l'itraconazole et le voriconazole sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon la gravité de l'infection ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections légères peuvent être traitées par voie orale, tandis que les cas graves nécessitent une perfusion."
}
},
{
"@type": "Question",
"name": "Combien de temps dure le traitement antifongique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement peut varier de plusieurs semaines à plusieurs mois selon la gravité."
}
},
{
"@type": "Question",
"name": "Des effets secondaires sont-ils associés aux antifongiques ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des nausées, des éruptions cutanées et des problèmes hépatiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les infections par Chrysosporium nécessitent-elles une hospitalisation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la gravité de l'infection; les cas graves peuvent nécessiter une hospitalisation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec Chrysosporium ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections systémiques graves et des lésions pulmonaires."
}
},
{
"@type": "Question",
"name": "Les infections par Chrysosporium peuvent-elles être mortelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en particulier chez les personnes immunodéprimées, elles peuvent être fatales."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications nécessitent souvent des traitements antifongiques intensifs et un suivi médical."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles le pronostic ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la présence de complications peut aggraver le pronostic et prolonger la durée de traitement."
}
},
{
"@type": "Question",
"name": "Les infections récurrentes sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections récurrentes peuvent survenir, surtout chez les patients immunodéprimés."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immunodépression, le diabète et l'exposition à des environnements humides."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru en raison d'un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Le diabète augmente-t-il le risque d'infection fongique ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut affaiblir le système immunitaire et augmenter le risque d'infections."
}
},
{
"@type": "Question",
"name": "Les traitements immunosuppresseurs sont-ils un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements immunosuppresseurs augmentent le risque d'infections fongiques."
}
},
{
"@type": "Question",
"name": "Les voyages dans des zones tropicales augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages dans des zones tropicales peuvent exposer à des agents pathogènes fongiques."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 02/05/2025
Contenu vérifié selon les dernières recommandations médicales
6 publications dans cette catégorie
Affiliations :
College of Resources and Environment, Hunan Agricultural University, Changsha 410128, PR China. Electronic address: A.Chen@hunau.edu.cn.
4 publications dans cette catégorie
Affiliations :
School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China. Electronic address: huliang2018@csu.edu.cn.
Publications dans "Chrysosporium" :
4 publications dans cette catégorie
Affiliations :
College of Chemistry and Environment Protection Engineering, Southwest Minzu University, Chengdu, 610041, PR China. Electronic address: yangst@pku.edu.cn.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
Department of Applied Biological Chemistry, Faculty of Agriculture, Meijo University, Nagoya, Aichi 468-8502, Japan. Electronic address: moshimi@meijo-u.ac.jp.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
Biocatalysis and Biosensing Laboratory, Department of Food Science and Technology, BOKU-University of Natural Resources and Life Sciences, Muthgasse 18, 1190, Vienna, Austria.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
Biocatalysis and Biosensing Laboratory, Department of Food Science and Technology, BOKU-University of Natural Resources and Life Sciences, Muthgasse 18, 1190, Vienna, Austria.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
Biocatalysis and Biosensing Laboratory, Department of Food Science and Technology, BOKU-University of Natural Resources and Life Sciences, Muthgasse 18, 1190, Vienna, Austria. roland.ludwig@boku.ac.at.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
Faculty of Agriculture, Kyushu University, 6-10-1 Hakozaki, Higashi-ku, Fukuoka, 812-8581, Japan.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Resources and Environment, Hunan Agricultural University, Changsha 410128, PR China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Resources and Environment, Hunan Agricultural University, Changsha 410128, PR China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Resources and Environment, Hunan Agricultural University, Changsha 410128, PR China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Environmental Science and Engineering, Hunan University and Key Laboratory of Environmental Biology and Pollution Control (Hunan University), Ministry of Education, Changsha 410082, PR China. Electronic address: zgming@hnu.edu.cn.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Environmental Science and Engineering, Hunan University and Key Laboratory of Environmental Biology and Pollution Control (Hunan University), Ministry of Education, Changsha 410082, PR China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Resources and Environmental Science, Yunnan Agricultural University, Kunming 650201, China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Resources and Environmental Science, Yunnan Agricultural University, Kunming 650201, China. Electronic address: xuzhi9910@126.com.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Environmental Science and Engineering, Hunan University, Changsha 410082, PR China; Key Laboratory of Environmental Biology and Pollution Control, Hunan University, Ministry of Education, Changsha 410082, PR China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Environmental Science and Engineering, Hunan University, Changsha 410082, PR China; Key Laboratory of Environmental Biology and Pollution Control, Hunan University, Ministry of Education, Changsha 410082, PR China.
Publications dans "Chrysosporium" :
2 publications dans cette catégorie
Affiliations :
School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China.
Publications dans "Chrysosporium" :
2 publications dans cette catégorie
Affiliations :
School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China.
Publications dans "Chrysosporium" :
The intravenous iron formulations ferric carboxymaltose (FCM) and ferric derisomaltose (FDI) offer the possibility of administering a large amount of iron in one infusion. This results in faster corre...
Ferric carboxymaltose therapy reduces symptoms and improves quality of life in patients who have heart failure with a reduced ejection fraction and iron deficiency. Additional evidence about the effec...
In this double-blind, randomized trial, we assigned ambulatory patients with heart failure, a left ventricular ejection fraction of 40% or less, and iron deficiency, in a 1:1 ratio, to receive intrave...
We enrolled 3065 patients, of whom 1532 were randomly assigned to the ferric carboxymaltose group and 1533 to the placebo group. Death by month 12 occurred in 131 patients (8.6%) in the ferric carboxy...
Among ambulatory patients who had heart failure with a reduced ejection fraction and iron deficiency, there was no apparent difference between ferric carboxymaltose and placebo with respect to the hie...
Co-extrusion of ferric pyrophosphate (FePP) with solubilizers, citric acid/trisodium citrate (CA/TSC), or ethylenediaminetetraacetic acid (EDTA) sharply increases iron absorption. Whether this can pro...
Our objectives were to 1) investigate the ligand coordination of iron, zinc, and solubilizers in extruded rice and test associations with iron solubility and absorption, 2) assess whether co-extrusion...
We produced labeled...
The addition of zinc and solubilizers created new iron coordination complexes of Fe(III) species with a weak ligand field at a high-spin state that correlated with solubility (r...
Rice extrusion of FePP with solubilizers resulted in bioavailable iron coordination complexes. In the case of FePP + CA/TSC, PA exerted similar inhibition of FIA as with FeSO...
Intravenous (IV) iron is the preferred treatment for patients with iron deficiency anemia (IDA) who require rapid replenishment of iron stores or in whom oral iron is not tolerated or effective. Data ...
RCTs reporting the incidence of blindly adjudicated cardiovascular events in IDA patients treated with IV iron were identified by systematic literature review (SLR). Pairwise random effects meta-analy...
The SLR retrieved 694 unique articles, of which four were RCTs reporting the incidence of the composite cardiovascular endpoint; two studies comparing FCM (N = 1529) with IS (N = 1505), and two studie...
Pooling data from four large-scale RCTs suggested that FDI was associated with significantly lower incidence of cardiovascular adverse events compared to both FCM and IS....
A multicenter, randomized, open-label, phase III study was conducted to compare the efficacy and safety of intravenous ferric derisomaltose (FDI) versus saccharated ferric oxide (SFO) in Japanese pati...
Bioremediation provides an environmentally sound solution for hydrocarbon removal. Although bioremediation under anoxic conditions is slow, it can be coupled with methanogenesis and is suitable for en...
The randomized IronIC trial evaluated the effect of intravenous ferric derisomaltose on physical capacity in iron-deficient, maintenance heart transplant (HTx) recipients. Iron deficiency was defined ...
We assessed key governors of iron homeostasis, such as hepcidin, soluble transferrin receptor (sTfR), and interleukin-6 (IL-6). We also measured growth factors and inflammatory markers with relevance ...
Hepcidin did not differ between HTx recipients and controls, even though markers of inflammation were modestly elevated. However, HTx recipients with ferritin <30 μg/L or sTfR above the reference rang...
HTx recipients with iron deficiency as defined in heart failure do not have elevated hepcidin levels, although inflammatory markers are modestly increased. The high ferritin cut-offs used in heart fai...
In this study, a fast, reproducible and simple-to-apply a new potentiometric determination method was developed for the evaluation of iron (III) reducing power (FRAP), one of the antioxidant capacity ...
The heterogeneous Fenton-like reaction (HeFR) has always been a research focus for environmental applications. However, it has long been difficult to reach a consensus on the reaction mechanism becaus...
Cardiovascular diseases are a leading cause of mortality and morbidity worldwide. Aberrant thrombosis is a common feature of systemic conditions like diabetes and obesity, and chronic inflammatory dis...